tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Positive Outlook for Medexus Pharmaceuticals: Buy Rating Affirmed by Analyst
RatingsPositive Outlook for Medexus Pharmaceuticals: Buy Rating Affirmed by Analyst
19h ago
Medexus Pharmaceuticals’ Earnings Call Highlights GRAFAPEX Success
PremiumCompany Announcements
Medexus Pharmaceuticals’ Earnings Call Highlights GRAFAPEX Success
3d ago
Medexus Pharmaceuticals Reports Strong FY 2025 Results and Successful GRAFAPEX Launch
PremiumCompany Announcements
Medexus Pharmaceuticals Reports Strong FY 2025 Results and Successful GRAFAPEX Launch
4d ago
MDP Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
MDP Upcoming Earnings Report: What to Expect?
7d ago
Medexus Pharmaceuticals Announces Fiscal Year 2025 Financial Results Conference Call
PremiumCompany Announcements
Medexus Pharmaceuticals Announces Fiscal Year 2025 Financial Results Conference Call
12d ago
Medexus Secures Public Reimbursement for Trecondyv® in Quebec
PremiumCompany AnnouncementsMedexus Secures Public Reimbursement for Trecondyv® in Quebec
2M ago
Medexus Reports Strong Initial Uptake of GRAFAPEX™ in U.S. Market
Premium
Company Announcements
Medexus Reports Strong Initial Uptake of GRAFAPEX™ in U.S. Market
3M ago
Medexus Returns Gleolan U.S. Rights to NX Development Corp.
Premium
Company Announcements
Medexus Returns Gleolan U.S. Rights to NX Development Corp.
4M ago
Medexus Launches GRAFAPEX in US, Eyes $100M Revenue
PremiumCompany Announcements
Medexus Launches GRAFAPEX in US, Eyes $100M Revenue
4M ago
Positive Growth Outlook for Medexus Pharmaceuticals Inc. Amid Strategic Expansion and Stable Performance
PremiumRatings
Positive Growth Outlook for Medexus Pharmaceuticals Inc. Amid Strategic Expansion and Stable Performance
5M ago
Medexus Pharmaceuticals: Robust Earnings Amidst Challenges
PremiumCompany Announcements
Medexus Pharmaceuticals: Robust Earnings Amidst Challenges
5M ago
Medexus Pharmaceuticals Inc.: Balancing Growth Potential and Risks with a Hold Rating
PremiumRatings
Medexus Pharmaceuticals Inc.: Balancing Growth Potential and Risks with a Hold Rating
5M ago
Medexus Pharmaceuticals Reports Strong Q3 2025 Results Amidst Strategic Growth
PremiumCompany AnnouncementsMedexus Pharmaceuticals Reports Strong Q3 2025 Results Amidst Strategic Growth
5M ago
Medexus Secures Ontario Public Reimbursement for Trecondyv
Premium
Company Announcements
Medexus Secures Ontario Public Reimbursement for Trecondyv
5M ago
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
Medexus Pharmaceuticals to Discuss Q3 2025 Results in Upcoming Conference Call
PremiumCompany Announcements
Medexus Pharmaceuticals to Discuss Q3 2025 Results in Upcoming Conference Call
5M ago
Medexus Pharmaceuticals Announces $30 Million Public Offering
PremiumCompany Announcements
Medexus Pharmaceuticals Announces $30 Million Public Offering
5M ago
Medexus Pharmaceuticals Launches Public Offering to Enhance Financial Flexibility
PremiumCompany Announcements
Medexus Pharmaceuticals Launches Public Offering to Enhance Financial Flexibility
5M ago
Medexus Secures FDA Approval for GRAFAPEX, Eyes $100M Revenue Milestone
PremiumCompany Announcements
Medexus Secures FDA Approval for GRAFAPEX, Eyes $100M Revenue Milestone
5M ago
Medexus Secures BC Reimbursement for Trecondyv
PremiumCompany AnnouncementsMedexus Secures BC Reimbursement for Trecondyv
6M ago
Medexus Pharmaceuticals Secures Deal for Trecondyv in Canada
Premium
Company Announcements
Medexus Pharmaceuticals Secures Deal for Trecondyv in Canada
7M ago
Medexus Pharmaceuticals Reports Strong Q2 2025 Results
Premium
Company Announcements
Medexus Pharmaceuticals Reports Strong Q2 2025 Results
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >